Beam Therapeutics (BEAM) Asset Utilization Ratio (2020 - 2025)

Beam Therapeutics (BEAM) has disclosed Asset Utilization Ratio for 6 consecutive years, with 0.1 as the latest value for Q4 2025.

  • Quarterly Asset Utilization Ratio rose 79.27% to 0.1 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.1 through Dec 2025, up 79.27% year-over-year, with the annual reading at 0.11 for FY2025, 118.18% up from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.1 at Beam Therapeutics, up from 0.04 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.29 in Q3 2024, with the low at 0.0 in Q2 2021.
  • Average Asset Utilization Ratio over 5 years is 0.09, with a median of 0.05 recorded in 2022.
  • The sharpest move saw Asset Utilization Ratio surged 176929.34% in 2022, then plummeted 85.66% in 2025.
  • Over 5 years, Asset Utilization Ratio stood at 0.04 in 2021, then grew by 14.85% to 0.05 in 2022, then surged by 506.87% to 0.27 in 2023, then plummeted by 79.67% to 0.06 in 2024, then surged by 79.27% to 0.1 in 2025.
  • According to Business Quant data, Asset Utilization Ratio over the past three periods came in at 0.1, 0.04, and 0.04 for Q4 2025, Q3 2025, and Q2 2025 respectively.